Proteomic analysis of lung cancer cells with natural resistance to gefitinib (IRESSA)

被引：0
|
作者：
Okano, Tetsuya [1 ]
Seike, Masahiro [1 ]
Gemma, Akihiko [1 ]
Kokubo, Yutaka [1 ]
Kataoka, Kiyoko [1 ]
Kudoh, Shoji [1 ]
Kondo, Tadashi [1 ]
Hirohashi, Setsuo [1 ]
机构：
[1] Nippon Med Sch, Tokyo, Japan
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3777
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
    Y Kokubo
    A Gemma
    R Noro
    M Seike
    K Kataoka
    K Matsuda
    T Okano
    Y Minegishi
    A Yoshimura
    M Shibuya
    S Kudoh
    British Journal of Cancer, 2005, 92 : 1711 - 1719
  • [2] Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
    Kokubo, Y
    Gemma, A
    Noro, R
    Seike, M
    Kataoka, K
    Matsuda, K
    Okano, T
    Minegishi, Y
    Yoshimura, A
    Shibuya, M
    Kudoh, S
    BRITISH JOURNAL OF CANCER, 2005, 92 (09) : 1711 - 1719
  • [3] Reduction of PTEN protein and loss of epidermal growth factor receptor (EGFR) gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
    Kokubo, Y
    Gemme, A
    Noro, R
    Seike, M
    Kataoka, K
    Matsuda, K
    Minegishi, Y
    Yoshimura, A
    Shibuya, M
    Kudoh, S
    LUNG CANCER, 2005, 49 : S71 - S71
  • [4] Gefitinib (Iressa) trials in non-small cell lung cancer
    Johnson, DH
    LUNG CANCER, 2003, 41 : S23 - S28
  • [5] Gefitinib (Iressa) for advanced non-small cell lung cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1138): : 77 - 78
  • [6] Iressa - Gefitinib - Astrazeneca - Treatment for lung cancer patients unresponsive to chemotherapy
    不详
    FORMULARY, 2003, 38 (06) : 350 - 350
  • [7] Cutaneous Adverse Reactions Induced by Gefitinib (Iressa) in Lung Cancer Patients
    Yun, Sook Jung
    Lee, Jee Bum
    Kim, Kyu Sik
    Kim, Young Chul
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2006, 61 (02) : 150 - 156
  • [8] Cell growth after withdrawal of gefitinib ('Iressa', ZD1839) in human lung cancer cells
    Satoh, H
    Ishikawa, H
    Nakayama, M
    Fujiwara, M
    Ohtsuka, M
    Sekizawa, K
    ONCOLOGY REPORTS, 2004, 12 (03) : 615 - 619
  • [9] Yuanhuadine, a natural diterpene, enhances the degradation of AXL to overcome acquired gefitinib-resistance in lung cancer cells
    Bae, S. Y.
    Hong, J. Y.
    Lee, H. J.
    Park, H. J.
    Lee, S. K.
    PLANTA MEDICA, 2015, 81 (11) : 890 - 890
  • [10] Gefitinib (IRESSA) sensitive lung cancer cell lines show constitutive phosphorylation of Akt
    Noro, Rintaro
    Gemma, Akihiko
    Kosaihira, Seiji
    Minegishi, Yuji
    Okano, Tetsuya
    Seike, Masahiro
    Kokubo, Yutaka
    Yoshimura, Akinobu
    Kudoh, Shoji
    CANCER RESEARCH, 2006, 66 (08)
12345